Company: CNS
Filing Date: 2025-03-21
Form Type: DEF 14A
Source: 0001284812-25-000127
Chunk: 22

Company: COHEN & STEERS, INC.
Filing Date: 2025-03-21
Form: DEF 14A
Chunk 22
---
 is independent under the NYSE listing standards and satisfies the independence requirements of Rule 10C-1 under the Exchange Act pertaining to Compensation Committee membership, and each is a “non-employee director” as defined in the applicable SEC rules. Rule 10C-1 establishes listing standards related to compensation committees, including with respect to (i) the independence of compensation committee members; (ii) the compensation committee’s authority to retain compensation consultants, independent legal counsel and other compensation advisors; (iii) funding for the independent compensation consultant and other outside advisors engaged by the compensation committee; and (iv) independence standards relating to any compensation consultant or other compensation advisor engaged by the compensation committee.

The Compensation Committee is responsible for overseeing the company’s compensation plans and programs and setting compensation for the company’s executive officers. The Compensation Committee has delegated authority (with certain limitations) to the chief executive officer to grant awards under the company’s Amended and Restated Stock Incentive Plan to employees who are not Section 16 officers. For additional information on the Compensation Committee’s responsibilities, see “Executive Compensation–Compensation Discussion and Analysis.”

#### The Nominating Committee
The Nominating Committee is currently comprised of Dr. Aggarwal (chair), Mr. Connor, Mses. Dolly, Smith and Wilson Thissen and Dr. Villani, each of whom is independent under the NYSE listing standards. The Nominating Committee is responsible for: (i) assisting the Board in identifying qualified director candidates; (ii) recommending to the Board the director nominees to be elected at annual meetings of shareholders; (iii) recommending to the Board nominees for each committee of the Board; (iv) overseeing executive succession

<div align='center'>19</div>

planning and making related recommendations to the Board; (v) recommending to the Board corporate governance guidelines applicable to the company; and (vi) overseeing the Board’s annual evaluation.

#### Meetings
The Board met six times in 2024. In 2024, the committees of the Board held the following number of meetings: Audit Committee – eight meetings; Compensation Committee – three meetings; and Nominating Committee – three meetings. During 2024, each director attended at least 75% of the meetings of the Board and each committee on which such director served during the period for which he or she served.

The Board believes that it is important for shareholders to have the opportunity to meet and talk to the independent directors. Therefore, the Board generally schedules a board meeting in conjunction with our